drugset / Trial / NCT01864174
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is determine if Metformin XR monotherapy in subjects with type 2 diabetes is non-inferior to Metformin IR monotherapy
Timeline
- Start
- 2013-06-20
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 500 mg | Oral |